In male rats, degarelix treatment produced aortic endothelial dysfunction, as did the other ADT treatments.
In plain wordsIn rats, degarelix produced aortic endothelial dysfunction compared with controls.
- Peptide
- Degarelix
- Outcome
- IncreaseAortic endothelial dysfunction
- Study
ratn: not reported in source
Male SD rats- Comparator
- Control group
- Outcome group
- Receptor activity and mechanism · Cardiovascular
- Studied dose
- Dose not stated · 24 weeksAs given in this study (rat).
Source sentences
In vascular reactivity assays, aorta, intrarenal, and coronary arteries of all three ADT groups showed endothelial dysfunction.
2 context sentences(design, population, supporting numbers)
Twenty-six 12-week-old male SD rats were divided into four groups for different types of ADTs including: the bilateral orchidectomy group (Orx), LHRH agonist group (leuprolide), LHRH antagonist group (degarelix), and control group.
After treated with drug or adjuvant injection every 3 weeks for 24 weeks, all rats were sacrificed and total blood were collected.